Accelerating Learning Health Systems Using Alicanto Collaboration Platforms
Yuri Quintana(St. Jude Children's Research Hospital), Tim Rebbeck(University of Pennsylvania), Andrew Lyu(Beth Israel Deaconess Medical Center), David J. Einstein(Beth Israel Deaconess Medical Center), Nuha El Sayed(Joslin Diabetes Center), Robin Joyce(Beth Israel Deaconess Medical Center), Carolyn Andrews(Dana-Farber Cancer Institute)
Cited by 2
Related Papers
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
|Blood|2010|866
Childhood cancer epidemiology in low‐income countries
|Cancer|2007|301
PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
|Journal of Immunotherapy|2011|285